Abstract

Imaging mass cytometry (IMC) is able to quantify the expression of dozens of markers at sub-cellular resolution on a single tissue section by combining a novel laser ablation system with mass cytometry. As such, it allows us to gain spatial information and antigen quantification in situ, and can be applied to both snap-frozen and formalin-fixed, paraffin-embedded (FFPE) tissue sections. Herein, we have developed and optimized the immunodetection conditions for a 34-antibody panel for use on human snap-frozen tissue sections. For this, we tested the performance of 80 antibodies. Moreover, we compared tissue drying times, fixation procedures and antibody incubation conditions. We observed that variations in the drying times of tissue sections had little impact on the quality of the images. Fixation with methanol for 5 min at −20°C or 1% paraformaldehyde (PFA) for 5 min at room temperature followed by methanol for 5 min at −20°C were superior to fixation with acetone or PFA only. Finally, we observed that antibody incubation overnight at 4°C yielded more consistent results as compared to staining at room temperature for 5 h. Finally, we used the optimized method for staining of human fetal and adult intestinal tissue samples. We present the tissue architecture and spatial distribution of the stromal cells and immune cells in these samples visualizing blood vessels, the epithelium and lamina propria based on the expression of α-smooth muscle actin (α-SMA), E-Cadherin and Vimentin, while simultaneously revealing the colocalization of T cells, innate lymphoid cells (ILCs), and various myeloid cell subsets in the lamina propria of the human fetal intestine. We expect that this work can aid the scientific community who wish to improve IMC data quality.

Highlights

  • In recent years, the development of a variety of single-cell technologies increased recognition of cellular heterogeneity both in physiological and pathological contexts

  • To develop the Imaging mass cytometry (IMC) antibody panel, we first evaluated the performance of an antibody panel previously developed for cell suspension mass cytometry [1]

  • This revealed that 18 out of the 36 antibodies were suitable for IMC on snapfrozen tissue

Read more

Summary

Introduction

The development of a variety of single-cell technologies increased recognition of cellular heterogeneity both in physiological and pathological contexts. Single-cell technologies based on RNA sequencing and mass cytometry (CyTOF) have been utilized to investigate cellular heterogeneity and identify novel cellular subsets [1, 2], and to discover biomarkers with clinical. Single-cell mass cytometry employs antibodies conjugated to stable metal isotopes, mostly from the lanthanide series, and is currently able to analyze over 40 different markers simultaneously, allowing an in-depth analysis of immune subsets. Imaging mass cytometry (IMC) is an extension of mass cytometry, which couples a laser ablation system with a mass cytometer [4] and has the ability to analyze up to 40 markers in a single tissue section. IMC has the potential to simultaneously characterize the composition of the immune compartment, the spatial relationship between immune cells and stromal cells, and the interactions among immune subsets in tissue sections of choice

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call